Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Finished Goods (2016 - 2021)

Historic Finished Goods for AtriCure (ATRC) over the last 13 years, with Q2 2021 value amounting to $21.6 million.

  • AtriCure's Finished Goods rose 2142.38% to $21.6 million in Q2 2021 from the same period last year, while for Jun 2021 it was $21.6 million, marking a year-over-year increase of 2142.38%. This contributed to the annual value of $20.6 million for FY2020, which is 2118.86% up from last year.
  • Per AtriCure's latest filing, its Finished Goods stood at $21.6 million for Q2 2021, which was up 2142.38% from $22.3 million recorded in Q1 2021.
  • In the past 5 years, AtriCure's Finished Goods ranged from a high of $22.3 million in Q1 2021 and a low of $10.8 million during Q3 2018
  • Its 5-year average for Finished Goods is $15.3 million, with a median of $14.1 million in 2017.
  • As far as peak fluctuations go, AtriCure's Finished Goods tumbled by 2679.07% in 2018, and later skyrocketed by 5382.39% in 2020.
  • Quarter analysis of 5 years shows AtriCure's Finished Goods stood at $13.4 million in 2017, then fell by 9.29% to $12.2 million in 2018, then skyrocketed by 40.13% to $17.0 million in 2019, then rose by 21.19% to $20.6 million in 2020, then increased by 4.81% to $21.6 million in 2021.
  • Its Finished Goods was $21.6 million in Q2 2021, compared to $22.3 million in Q1 2021 and $20.6 million in Q4 2020.